These results indicate that Que further increases the phosphorylation of JAK2 on the JAK/STAT1 pathway by activating IFNγ-R on tumor cells and increases the nuclear localization of p-STAT1, thus reducing the expression of PD-L1 on the precancerous cells of breast cancer. Here, IFNGR1 is linked to breast carcinoma.